Patent directory · USPTO A61K / A61P
Patents matching “The United States of America as represented by the Secretary of the Department of”
389 pharma patents match "The United States of America as represented by the Secretary of the Department of" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 389 pharmaceutical patents matching "The United States of America as represented by the Secretary of the Department of" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8410063
N-acetyl mannosamine as a therapeutic agent
granted -
US 8394387
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
granted -
US 8394764
Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use
granted -
US 8388933
Multimeric protein toxins to target cells having multiple identifying characteristics
granted -
US 8389495
Olioodeoxynucleotide and its use to induce an immune response
granted -
US 8378071
Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis
granted -
US 8367074
Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
granted -
US 8357525
Thermal inactivation of rotavirus
granted -
US 8357783
Human anti-mesothelin monoclonal antibodies
granted -
US 8349568
Method of diagnosing poor survival prognosis colon cancer using let-7g
granted -
US 8343725
Method of diagnosing poor survival prognosis colon cancer using miR-10a
granted -
US 8343499
Anti-arthropod vector vaccines, methods of selecting and uses thereof
granted -
US 8338102
Method of diagnosing poor survival prognosis colon cancer using miR-181b
granted -
US 8338103
Method of diagnosing poor survival prognosis colon cancer using miR-106a
granted -
US 8338106
Method of diagnosing poor survival prognosis colon cancer using miR-29a
granted -
US 8337860
Development of dengue virus vaccine components
granted -
US 8338105
Method of diagnosing poor survival prognosis colon cancer using miR-203
granted -
US 8338457
Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist
granted -
US 8334260
sFRP and peptide motifs that interact with sFRP and methods of their use
granted -
US 8313746
Human monoclonal antibodies against hendra and nipah viruses
granted -
US 8309701
Variants of human taste receptor genes
granted -
US 8298525
Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
granted -
US 8282926
CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5
granted -
US 8278348
Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof
granted